Friday, 11 September 2009
Tabled
1
| 07.30–09.00 | Registration | |
| 09.00–09.10 | Welcome and introduction | Plenary room |
| W. Artibani, Padua (IT) | ||
| A. Sikorski, Szczecin (PL) | ||
| 09.10–10.30 | Penile surgery | Plenary room |
| 09.10–09.30 | Update on management of penile cancer | |
| T. Demkow, Warsaw (PL) | ||
| 09.30–09.50 | Surgical correction of urethral strictures | |
| O. Lindell, Helsinki (FI) | ||
| 09.50–10.10 | The treatment of Peyronie's disease | |
| K. Krajka, Gdansk (PL) | ||
| 10.10–10.30 | Why circumcision is not mutilation | |
| M. Marberger, Vienna (AT) | ||
| 10.30–10.50 | Coffee break and poster viewing |
Tabled
1
| 10.50–12.30 | Poster session 1: Prostate Cancer | Room 1 |
|---|---|---|
| N1. | Audit of PSA and Gleason scoring in prostatic carcinoma, J.A. Al Shakarchi*, D.Wasfi (Birmingham, Dudley, United Kingdom) | |
| N2. | Variations in RNASEL, MSR1 and E-cadherin genes and prostate cancer in Poland, B.P. Gliniewicz*, C. Cybulski, D.Wokołorczyk, A. Sikorski, J. Lubiński (Szczecin, Poland) | |
| N3. | Pelvic floor muscles evaluation in patients with erectile dysfunction after radical prostatectomy, T.G. Markosyan*, V. Grigoryan, S.S. Nikitin (Moscow, Russia) | |
| N4. | Phase II study of ketoconazole combined with weekly doxorubicin in patients with hormone-refractory prostate cancer, D. Argirovic*, A. Argirovic (Belgrade, Serbia) | |
| N5. | The use of CT in the staging of prostate cancer, M. Rohrsted*, K.J. Mikines (Copenhagen, Denmark) | |
| N6. | BRCA2 gene mutation characterization in hereditary prostate cancer patients in Latvia, A. Abele, J. Plonis*, E. Miklasevics, E. Vjaters, A. Irmejs, J. Gardovskis, G. Trofimovics (Riga, Latvia) | |
| N7. | Trinucleotide repeat length polymorphisms of the androgen receptor gene – a step forward in understanding the pathogenesis of prostate cancer, A. Lemiński*, A. Bińczak-Kuleta, M. Kaczmarczyk, M. Ostanek, K. Skonieczna, M. Kryształowska, B. Łoniewska, A. Ciechanowicz, M. Słojewski, A. Sikorski (Szczecin, Poland) | |
| N8. | Clinical and histopathological characteristics of Finnish familial prostate cancers, S. Pakkanen*, M.P. Matikainen, N. Ha, P. Kujala, P.A. Koivisto, J. Schleutker, T.L.J. Tammela (Tampere, Finland) | |
| N9. | Impact of Neoadiuvant Hormonal Therapy (NHT) on prostate cancer Gleason score and staging based on the comparison of TRUScoreBx and post radical prostatectomy specimens, P. Sikorska-Radek, M. Soczawa*, J. Smigielski, J. Matych (Lodz, Szczecin, Poland) | |
| N10. | Volume and localization of the prostate tumor as the predictive factors of the prostate cancer stage, A.I. Urbansky* (St. Petersburg, Russia) | |
| N12. | Preventive role of postoperatively early introduced intracavernosal PGE1 injections on the development of blood flow disturbances in penis after radical prostatectomy, P. Petrasz*, M. Słojewski, A. Lemiński, A. Gołubiński, A. Sikorski (Szczecin, Poland) | |
| N13. | Minimal-invasive surgery – what do we mean by this? Radical perineal prostatectomy (suprasphincteric) RPP and Transperineal Lymphadenectomy (TPL) as minimal-invasive method of the treatment of prostate cancer. Technique of the procedure and own experience, S. Wronski* (Bydgoszcz, Poland) | |
| N14. | Could the effect of therapy depend on the prostate movements during irradiation?, H.A. Urbańczyk*, L. Hawrylewicz, L. Misztal, I. Wesołowska, W. Majewski, J. Ciechowicz, L. Miszczyk, K. Ś losarek (Gliwice, Łódz, Poland) | |
| N15. | Surgical anatomy of the prostatic urethra. A pilot ex vivo study, A. Antoniewicz*, P. Chlosta, J. Jaskulski, S. Poletajew, L. Zapala, A. Borówka (Warsaw, Poland) | |
| N16. | Vascular disorders in cavernosal bodies limit the effectiveness of treatment of erectile dysfunction following radical prostatectomy, P. Petrasz*, M. Słojewski, A. Gołąb, A. Sikorski (Szczecin, Poland) | |
| N17. | TMPRSS2: ERG gene fusion and epigenetic changes in tumour suppressor genes are associated with clinical markers of poor prognosis in prostate cancer patients, F. Jankevicius*, S. Jarmalaite, R. Sabaliauskaite, N. Kalinauskaite, D. Dasevicius, A. Laurinavicius, J. Lazutka (Vilnius, Lithuania) | |
| N18. | How to improve the reconstruction of prostate MRI imaging to transrectal ultrasound imaging?, S. Bąk*, W. Lipczyński, B. Glazar, Z. Dobrowolski, A. Urbanik, R. Chrzan (Cracow, Poland) | |
Tabled
1
| 10.50–12.30 | Poster session 2: BPH and Prostate Biopsy | Room 2 |
|---|---|---|
| N19. | Autonomic nervous system activity in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia estimated by heart rate variability, K. Juszczak*, M. Mazur, M. Wyczółkowski, P.J. Thor (Cracow, Poland) | |
| N20. | Tamsulosin with or without serenoa repens in benign prostatic hyperplasia: The Comb TAMSR trial, D. Argirovic* (Belgrade, Serbia) | |
| N21. | Comparative effects of rosuvastatin and simvastatin on growth of normal prostatic epithelial cells at clinically relevant concentrations, T. Murtola*, H. Syvälä, P. Pennanen, M. Bläuer, T. Ylikomi, T.L.J. Tammela (Jyväskylä, Tampere, Finland) | |
| N22. | The diode laser: The new laser system for the transurethral vaporization of prostate – preliminary experience, M. Gałęski*, A. Sikorski (Szczecin, Poland) | |
| N23. | Lower urinary tract symptoms and their severity in men subjected to prostate biopsy due to suspicion of prostate cancer, L. Nyk*, J. Dobruch, A. Borówka, E. Modzelewska, J. Tyloch, B. Misterek, E. Czapkowicz, E. Bres-Niewada, E. Keller (Warsaw, Bydgoszcz, Poland) | |
| N24. | Comparison of two simple algorithms avoiding unnecessary prostate biopsy in PSA based prostate cancer detection program, R. Adomaitis*, A. Zalimas, F. Jankevicius (Vilnius, Lithuania) | |
| N25. | Are sextant biopsies still justified?, D. Milonas*, A. Zabarskas, J. Masilunas, K. Kucinskas, S. Auskalnis, M. Jievaltas (Kaunas, Lithuania) | |
| N26. | Repeat prostate biopsies – when and for whom?, D. Milonas, A. Grybas*, A. Zabarskas, J. Masiliunas (Kaunas, Lithuania) | |
| N27. | Is there a need of routine pathological examination of all tissue specimens taken during benign prostate hyperplasia surgery?, M. Skrzypczyk, S. Poletajew*, J. Dobruch, A. Antoniewicz, T. Dzik, A. Borówka (Warsaw, Poland) | |
| N28. | Reduction of PSA values after levofloxacin therapy in patients with PSA greater than 4 ng/ml: Implications for prostate cancer detection, G. Bozdogan, B. Erol*, B. Akduman, H. Tokgoz, I. Donmez, G. Mungan, N.A. Mungan (Zonguldak, Turkey) | |
| N29. | Photoselective vaporization of the prostate with Greenlight HPS 120 W laser in patients with benign prostatic hyperplasia – results of treatment of first 100 consecutive patients, H. Zieliński, G. Piotrowicz* (Warsaw, Poland) | |
| N30. | Green laser vaporization of the prostate – 300 procedures experience, M. Lipinski*, L.M. Jeromin, W. Różański (Todz, Lodz, Poland) | |
| N31. | Detection rate of prostate cancer in double sextant biopsy regions, A.E. Pryalukhin*, A.I. Urbansky, M.E. Topuzov (Saint Petersburg, Russia) | |
| N32. | Determination of free/total prostate specific antigen ratio in different age categories for diagnosis of prostate carcinoma, B. Erol*, N.A. Mungan, K. Onem, B. Akduman, G. Bozdogan, G. Mungan, H. Tokgoz, C. Eken (Zonguldak, Istanbul, Antalya, Turkey) | |
Tabled
1
| 10.50–12.30 | Poster session 3: Bladder Cancer | Room 3 |
|---|---|---|
| N33. | The rate of incidental prostate cancer in patients who underwent radical cystoprostatectomy and its clinical significance, M. Sunay*, L. Emir, S. Bagbancı, M. Dadalı, D. Erol (Ankara, Turkey) | |
| N34. | The evaluation of recurrence rates within the first year for Ta T1 low and intermediate transitional cell carcinoma of the bladder to change the routine follow-up cystoscopies, S. Güney, S. Arısan, C. Sönmez*, E. Ergenekon (erIdot;stanbul, Turkey) | |
| N35. | Pathophysiological and clinical problems after urinary diversion, R. Bliucukis*, S. Walter (Odense, Denmark) | |
| N36. | Laparoscopic nephroureterectomy combined with transurethral laser excision of a rosette in urinary bladder as a modern treatment method of upper urinary tract carcinomas (Preliminary report), J. Kawecki, A. Szedel, M. Tkocz, H. Augustyniak, W. Pawlowski, M. Kupajski* (Katowice, Poland) | |
| N37. | Macroscopic haematuria – a leading urological problem in patients on anticoagulant therapy. Is the common diagnostic standard still advisable?, A. Antoniewicz, L. Zapala*, S. Poletajew, A. Borówka (Warsaw, Poland) | |
| N38. | How accurate we really are in predicting final stage of non-invasive TCC of the bladder when performing cystoscopy?, A. Antoniewicz, P. Chlosta, M. Skrzypczyk*, A. Borówka (Warsaw, Poland) | |
| N39. | The evaluation of the angiotensin-converting enzyme gene polymorphism in Ta,T1 and invasive bladder cancer, N.A. Mungan, B. Erol*, G. Bozdogan, A. Dursun, S. Bozdogan, S. Baltaci, K. Onem, A. Zumrut, H. Tokgoz (Zonguldak, Ankara, Istanbul, Turkey) | |
| N40. | Optical coherent tomography for surgery and urology using: A systematic review, S. Kharchenko*, T. Drewa, B. Sikorski (Bydgoszcz, Poland) | |
| N41. | Expression levels of P53 and CDKN2a/ARF messenger RNA detected by Real-Time PCR in tumor tissue in bladder cancerclinicopathological applications, E.M. Borkowska*, M. Traczyk, A. Jedrzejczyk, M. Pietrusinski, B.A. Kaluzewski (Lodz, Poland) | |
| N42. | Interesting tumor case – lymphoma of the bladder, L. Wojnar*, Z. Kwias, M. Malkowski, A. Antczak, W. Malendowicz (Poznań, Poland) | |
| N43. | Is Carcinoma In Situ (CIS), a contra-indication for neoadjuvant chemotherapy for Transitional Cell Carcinoma (TCC) of the bladder?, M.S. Ahmad*, J. Cresswell, N.U. Eronini, J.E. Whiteway, A.C. Thorpe (Stockton on Tees, Middlesbrough, United Kingdom) | |
| N44. | The value of combined transurethral resection and adjuvant hormonal therapy in treatment of bladder endometriosis, T. Borkowski*, B. Kuzaka, J. Michalec (Warsaw, Poland) | |
| N45. | Laparoscopic partial nephroureterectomy in the treatment of hydronephrosis of the upper pole of duplex kidney with megaureter, P. Wiśniewski*, P. Jarzemski, S. Listopadzki, R. Kalinowski (Bydgoszcz, Poland) | |
Tabled
1
| 12.30–13.30 | Lunch | |
| 13.30–14.50 | Early diagnosis of prostate cancer–risks and benefits | Plenary room |
| 13.30–13.50 | The new data | |
| M. Graefen, Hamburg (DE) | ||
| 13.50–14.10 | Biopsy technique to avoid detecting cancers not to be detected | |
| A. Golab, Szczecin (PL) | ||
| 14.10–14.30 | Evaluating the aggressive potential in the individual patient | |
| T. Tammela, Tampere (FI) | ||
| 14.30–14.50 | Biochemical failure after curative treatment | |
| R. Zdrojowy, Wroclaw (PL) | ||
| 14.50–15.20 | Coffee break and poster viewing | |
Tabled
1
| 15.20–17.00 | Poster session 4: Overactive bladder, Incontinence, Prostatitis, Miscellaneous | Room 1 |
|---|---|---|
| N46. | Animal models of overactive bladder: Cyclophosphamide (CYP)-induced cystitis in rats, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow, Poland) | |
| N47. | Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic overactive bladder model rats, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow, Poland) | |
| N48. | Alterations in urinary bladder histological structure and mast cells activity following overactive bladder in rats, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow, Poland) | |
| N49. | Male sling operations in male urinary incontinence, M. Sunay*, L. Emir, M. Dadalı, S. Bagbancı, D. Erol (Ankara, Turkey) | |
| N50. | Associations between lower urinary tract symptoms and semen quality in ageing male, K. Ausmees*, M. Źarkovski, G. Timberg, P. Korrovits, M. Punab (Tartu, Tallinn, Estonia) | |
| N51. | Prevalence of asymptomatic inflammatory prostatitis in ageing male with lower urinary tract symptoms, K. Ausmees*, M. Źarkovski, G. Timberg, P. Korrovits, M. Punab (Tartu, Estonia) | |
| N52. | Prognostic clinical markers for asymptomatic prostatitis in ageing male with lower urinary tract symptoms, K. Ausmees*, M. Źarkovski, G. Timberg, P. Korrovits, M. Punab (Tartu, Tallinn, Estonia) | |
| N53. | The role of hyperosmolarity in micturition: Physiological model of overactive bladder, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow, Poland) | |
| N54. | Does the number of prostatic epithelial progenitors depend on age?, L. Pokrywka*, M. Jasinski, A. Kaznica, P. Chlosta, T. Drewa, Z. Wolski (Bydgoszcz, Kielce, Poland) | |
| N55. | An analysis of the main causes and evaluation of the results of a surgical treatment of vesico-vaginal fistulas, T. Gawlik-Jakubczak*, A. Klejnotowska, K. Krajka (Gdynia , Gdansk, Poland) | |
| N56. | Is botulinum toxin type A intraprostatic injections effective in patients with urinary retention?, M. Jasinski*, T. Drewa, J. Tyloch, Z. Wolski (Bydgoszcz, Poland) | |
| N57. | Three-dimensional ultrasonography (3D USG) administration in evaluation antibiotic distribution given intraprostatic injection during chronic prostatitis, J. Tyloch*, Z. Wolski, T. Drewa (Bydgoszcz, Poland) | |
| N58. | Difficulties of qualification in patients to implant an artificial urethral sphincter, Z. Wolski, M. Gruszczyński*, M. Tworkiewicz (Bydgoszcz, Poland) | |
| N59. | Improvement of nocturnal enuresis after adenotonsillectomy in children with obstructive sleep apnea syndrome, A. Gökçe*, S. Aslan, F.R. Yalçınkaya, M. Davarcı, Y.S. Kaya, N. Savas, S. Gorur, S. Dagli, A.N. Kiper, M.D. Balbay (Hatay, Turkey) | |
| N60. | Treatment of the stress incontinence using different types of Trans Obturator Tape (TOT) in women – analysis of failures after surgery, M. Mikulska-Jovanović, Z. Wolski, A. Łapuć, L. Pokrywka* (Bydgoszcz, Poland) | |
Tabled
1
| 15.20–17.00 | Poster session 5: Renal disease | Room 2 |
|---|---|---|
| N62. | Laparoscopic living donor nephrectomy – first Polish cases experience, M. Słojewski*, A. Gołąb, K. Ciechanowski, T. Sulikowski, L. Domański, M. Ostrowski, A. Sikorski (Szczecin, Poland) | |
| N63. | Natural history of renal tumors in von Hippel-Lindau syndrome, B.P. Gliniewicz*, C. Cybulski, J. Lubiński, A. Sikorski (Szczecin, Poland) | |
| N64. | The results of multidisciplinary treatment of metastatic renal cell carcinoma, H. Zieliński, A. Wieczorek*, A. Małczyński, J. Anusik, W. Chudzik (Warsaw, Poland) | |
| N65. | Survival analysis for localized low-differentiated renal cell carcinoma, A. Gołubiński*, B. Gliniewicz, M. Słojewski, A. Sikorski (Szczecin, Poland) | |
| N66. | Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in acute renal trauma model in heparinized rats, H. Tokgoz, K. Karakaya, V. Hanci, M. Abdusoglu, B. Erol*, O. Turksoy, B. Akduman, N.A. Mungan (Zonguldak, Turkey) | |
| N67. | RFA of the tumors in the solitary kidney, M. Matuszewski*, J. Michajłowski, K. Krajka (Gdańsk, Poland) | |
| N68. | Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats, A. Gökçe*, S. Oktar, M. Aydın, S. İlhan, Z. Yönden, O.V. Ozkan, M. Davarcı, F.R. Yalçınkaya (Hatay, Elazıg, Turkey) | |
| N69. | Changes in peripheral blood mononuclear cells subpopulation after RFA in patients with renal cell carcinoma, J. Michajłowski*, M. Matuszewski, I. Michajłowski, K. Ruckermann-Dziurdzińska, J.M. Witkowski, W. Biernat, K. Krajka (Gdańsk, Poland) | |
| N70. | Systemic inflammatory reactions in patients after radiofrequency ablation of renal cell carcinoma, M. Matuszewski*, J. Michajłowski, I. Michajłowski, K. Krajka (Gdańsk, Poland) | |
| N71. | The frequency of clinical symptoms in kidney cancer cases, R. Baltrimavicius*, A. Patasius, D. Milonas, M. Jievaltas (Kaunas, Lithuania) | |
| N72. | Tumor size influence on cancer specific and overall survival after surgical renal carcinoma treatment, M. Milonas*, R. Baltrimavicius, A. Patasius, M. Jievaltas, S. Auskalnis (Kaunas, Lithuania) | |
| N73. | Laparoscopic heminephrectomy in adult patients – initial experience, T. Borkowski*, J. Michalec, E. Bres (Warsaw, Poland) | |
| N74. | Laparoscopic nephron sparing surgery: Early results of 38 cases, P. Slupski*, P. Jarzemski, S. Listopadzki (Bydgoszcz, Poland) | |
| N75. | Should we broaden indications for treatment of T3c renal cell carcinoma with atrial thrombus?, S. Bąk*, Z. Dobrowolski, W. Lipczyński, B. Glazar, J. Sadowski (Cracow, Poland) | |
Tabled
1
| 17.00–17.30 | Debate: Androgen supplementation in aging males | |
| Chair: B. Darewicz, Bialystok (PL) | ||
| Pro: P. Korrovits, Tartu (EE) | ||
| Con: T. Drewa, Bydgoszcz (PL) | ||
| 17.30–18.00 | Lecture: Improving TUR-B with fluorescence cystoscopy | Plenary room |
| Sponsored by GE Healthcare | ||
Saturday, 12 September 2009
Tabled
1
| 08.00–09.20 | Prostate cancer–the burden of treatment | Plenary room |
| 08.00–08.20 | Active surveillance benefits and burden | |
| A. Rannikko, Helsinki (FI) | ||
| 08.20–08.40 | Voiding and storage dysfunction | |
| J. Nordling, Herlev (DK) | ||
| 08.40–09.00 | Management of ED | |
| A. Sikorski, Szczecin (PL) | ||
| 09.00–09.20 | Managing the burden of androgen deprivation | |
| M. Graefen, Hamburg (DE) | ||
| 09.20–09.50 | State-of-the-art lecture: What the urologist needs to know in female stress incontinence | |
| W. Artibani, Padua (IT) | ||
| 09.50–10.10 | Coffee break and poster viewing | |
Tabled
1
| 10.10–11.50 | Poster session 6: External genital | Room 1 |
|---|---|---|
| N76. | Results of an analgesia method in varicocelectomy under local anaesthesia for pain relief, A.B. Baseskioğlu* (Osmaniye, Turkey) | |
| N77. | Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumor of testis, S. Güney, N. Güney, C. Sönmez*, E. Ergenekon (İstanbul, Turkey) | |
| N78. | Endoscopic versus open hydrocelectomy for the treatment of adult hydroceles, L. Emir, M. Sunay*, Y. Karakaya, M. Dadalı, D. Erol (Ankara, Turkey) | |
| N79. | Coenzyme Q10 treatment reduces lipid peroxidation, inducible and endothelial nitric oxide synthases and germ cell-specific apoptosis in testicular ischemia/reperfusion injury, B. Erol*, M. Bozlu, V. Hanci, H. Tokgoz, S. Bektas, G. Mungan (Zonguldak, Mersin, Turkey) | |
| N80. | Fournier's gangrene: Overview of prognostic factors and definition of new prognostic parameter, B. Erol*, A. Tuncel, V. Hanci, H. Tokgoz, A. Abdulkadir, B. Akduman, E. Kargi (Zonguldak, Ankara, Turkey) | |
| N81. | Long-term outcome after postchemotherapy retroperitoneal lymphadenectomy in patients with residual teratoma, D. Argirovic*, A. Argirovic, V. Stanic (Belgrade, Serbia) | |
| N82. | Comparison of local anaesthetic effects of tramadol with prilocaine during circumcision procedure, E. Kargi, A. Isıkdemir, H. Tokgoz, B. Erol*, F. Isıkdemir, V. Hanci, C. Payasli (Zonguldak, Turkey) | |
| N83. | High risk clinical stage A nonseminomatous testicular tumors: Primary retroperitoneal lymphadenectomy or cisplatin-based chemotherapy?, D. Argirovic*, A. Argirovic (Belgrade, Serbia) | |
| N84. | Extremely low occurrence of late events following adjuvant carboplatin chemotherapy for clinical stage A seminomatous testicular tumors, D. Argirovic*, A. Argirovic (Belgrade, Serbia) | |
| N85. | Surgical treatment of hypererectio, J.E. Baginska*, W. Piaskowski, K. Krajka (Gdańsk, Poland) | |
| N86. | Hereditary behavior of varicocele, A. Gökçe*, M. Davarcı, F.R. Yalçınkaya, E.O. Güven, Y.S. Kaya, M.R. Helvacı, M.D. Balbay (Hatay, Turkey) | |
| N87. | Relationship of varicocele with height and obesity in men presenting with infertility, A. Gökçe*, M. Davarcı, F.R. Yalçınkaya, E.O. Güven, M.D. Balbay (Hatay, Turkey) | |
| N88. | Protective effect of vitamine E and melatonin against radiation induced damage in testis of rat, F.R. Yalçınkaya, A. Gökçe*, E.O. Güven, M. Davarcı, G. Cikim, H. Yekeler, M.D. Balbay (Hatay, Kahramanmaraş, Elazig, Turkey) | |
| N89. | Usefulness of dermoscopy for differentiation of pearly penile papules and genital warts, I. Michajłowski*, J. Michajłowski, M. Sobjanek, A. Włodarkiewicz, M. Matuszewski, K. Krajka (Gdańsk, Poland) | |
| N90. | The real-life safety and efficacy of vardenafil: an international post-marketing surveillance study – results from 2543 Polish patients, B. Darewicz, J. Kudelski*, M. Skrodzka, M. Chlabicz, E. Malczyk (Bialystok, Poland) | |
| N91. | Peyronie's disease – surgical treatment outcomes, A. Zelvys*, B. Dainys, F. Jankevicius (Vilnius, Lithuania) | |
| N92. | Sequential high-dose chemotherapy with hematopoietic stem-cell support in poor risk, relapsed or refractory germ-cell tumor patient treatment: Lithuanian experience, J. Korsakas*, K. Andrekute-Aleksiejiene, A. Bukauskas, B. Brasiuniene, I. Trociukas, F. Jankevicius, L. Griskevicius (Vilnius, Lithuania) | |
| N93. | The value of radical radiotherapy in patients with penile cancer, W. Majewski, B. Bojanowski* (Gliwice, Poland) | |
Tabled
1
| 10.10–11.50 | Poster session 7: Stones and Reconstruction | Room 2 |
|---|---|---|
| N94. | Impact of stone location on success rates of ureteroscopic pneumolithotripsy, C. Sönmez*, S. Arısan, S. Güney, O. Akca, A. Dalkılıc, E. Ergenekon (İstanbul, Turkey) | |
| N95. | Heavy metals in stones and urine of stone formers, M. Słojewski*, B. Czerny, K. Safranow, A. Pawlik, M. Droździk, E. Byra, A. Gołąb, D. Chlubek, A. Sikorski (Szczecin, Poland) | |
| N96. | Urethral pull-through operation for posterior urethral stricture: Outcomes of a 20-year experience, M. Sunay*, M. Dadalı, A. Karabulut, L. Emir, D. Erol (Ankara, Turkey) | |
| N97. | Calcium phosphate stone morphology: plain radiographic findings and interobserver variabilities, H. Tokgoz, O. Turksoy, A. Yildiz, I. Unal, B. Erol*, S. Toparli, G. Mungan (Zonguldak, Adana, Urfa, Turkey) | |
| N98. | Pain perception during shock wave lithotripsy (SWL): Does it correlate with patient and stone characteristics?, H. Tokgoz, V. Hanci, O. Turksoy, B. Erol*, B. Akduman, A. Mungan (Zonguldak, Turkey) | |
| N99. | Comparison of the analgesic effects of dexketoprofen and diclofenac during shockwave lithotripsy: A randomized, double-blind clinical trial, H. Tokgoz, S. Yurtlu, V. Hanci, O. Turksoy, B. Erol*, B. Akduman, A. Mungan (Zonguldak, Turkey) | |
| N100. | The alternative technique of ureterointestinal anastamosis with antireflux protection, I.G. Aghajanyan, A.A. Tsaturyan, Sh.B. Danielyan, O.E. Dilanyan* (Yerevan, Armenia; Moscow, Russia) | |
| N101. | The analysis of the way of the treatment of staghorn stones in a kidney, J. Kawecki, W. Duda, H. Augustyniak, P. Chwastek* (Katowice, Poland) | |
| N102. | Feasibility of prepuce reconstruction in hypospadias repair, M.K. Orkiszewski*, J.A. Madej (Poznań, Bydgoszcz, Poland) | |
| N103. | Colics from the heart, M.S. Ahmad*, B.D.R. Gowda, D. Chadwick, G.P. Naisby (Stockton on Tees, Middlesbrough, United Kingdom) | |
| N104. | Reimplantation of the strictured ureter – laparoscopic approach, A. Gołąb*, M. Słojewski, M. Soczawa, B. Gliniewicz, A. Sikorski (Szczecin, Poland) | |
| N105. | Evaluation of renal function following extracorporeal shock wave lithotripsy (ESWL): The use of parametric clearance kidney scintigrams, T. Konecki*, I. Frieske, J. Kusmierek, M. Sosnowski (Lodz, Poland) | |
| N106. | Nephrostomy in pregnancy, L. Wojnar*, A. Antczak, Z. Kwias (Poznań, Poland) | |
| N107. | Hair stem cells for bladder regeneration in rats, preliminary results, T. Drewa*, R. Joachimiak, A. Kaznica, V. Sarafian, M. Pokrywczynska (Bydgoszcz, Poland; Plovdiv, Bulgaria) | |
Tabled
1
| 11.50–12.30 | Debate on chemoprevention of prostate cancer | Plenary room |
| Chair: M. Graefen, Hamburg (DE) | ||
| Benefits: M. Marberger, Vienna (AT) | ||
| Risks: W. Artibani, Padua (IT) | ||
| 12.30 | Awards and closing remarks | |
| A. Sikorski, Szczecin (PL) | ||
| M. Marberger, Vienna (AT) | ||
Article info
Identification
Copyright
© 2009 European Association of Urology. Published by Elsevier Inc. All rights reserved.
